Off-label uses of trastuzumab.
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D054598:Blue Cross Blue Shield Insurance Plans; D017277:Drug Approval; D004348:Drug Labeling; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents